South Harz Potash Limited (ASX:SHP)

Oncternal Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	0.57	0.25	2.27	6.6	8.24	0.14
Short-Term Investments	0.08	0.06	0.12	0.03	0.03	-
Cash & Short-Term Investments	0.65	0.32	2.39	6.63	8.27	0.14
Cash Growth	-70.34%	-86.76%	-63.94%	-19.82%	5720.82%	-79.54%
Other Receivables	0.14	0.19	0.18	0.66	0.04	0.04
Receivables	0.14	0.19	0.18	0.66	0.04	0.04
Prepaid Expenses	-	-	-	-	-	0.02
Other Current Assets	-	-	-	-	-	0.15
Total Current Assets	0.79	0.51	2.57	7.3	8.31	0.35
Property, Plant & Equipment	2.14	2.07	2.16	1.9	1.97	3.18
Total Assets	2.93	2.58	4.73	9.19	10.28	3.53
Accounts Payable	1.71	1.79	0.74	-	0.35	0.24
Accrued Expenses	-	-	-	-	-	0.03
Other Current Liabilities	0.17	0.31	0.6	0.94	-	0.1
Total Current Liabilities	1.88	2.09	1.34	0.94	0.35	0.37
Total Liabilities	1.88	2.09	1.34	0.94	0.35	0.37
Common Stock	41.48	39.39	33.73	30.92	20.55	11.13
Retained Earnings	-43.03	-41.36	-32.21	-23.61	-11.75	-8.25
Comprehensive Income & Other	2.6	2.46	1.87	0.95	1.14	0.28
Shareholders' Equity	1.05	0.49	3.39	8.25	9.94	3.16
Total Liabilities & Equity	2.93	2.58	4.73	9.19	10.28	3.53
Net Cash (Debt)	0.65	0.32	2.39	6.63	8.27	0.14
Net Cash Growth	-70.34%	-86.76%	-63.94%	-19.82%	5720.82%	-79.54%
Net Cash Per Share	0.00	0.00	0.00	0.01	0.03	0.00
Filing Date Shares Outstanding	1,053	944.18	713.51	532.68	424.1	197.05
Total Common Shares Outstanding	1,053	827.18	600.01	532.03	424.1	172.51
Working Capital	-1.09	-1.59	1.23	6.36	7.96	-0.02
Book Value Per Share	0.00	0.00	0.01	0.02	0.02	0.02
Tangible Book Value	1.05	0.49	3.39	8.25	9.94	3.16
Tangible Book Value Per Share	0.00	0.00	0.01	0.02	0.02	0.02

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.